A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients

NCT02619058 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University Cancer Hospital & Institute